Overtreatment Avoidance

Overtreatment Avoidance is a clinical decision-making framework within active surveillance that distinguishes itself by prioritizing the deferral or exclusion of aggressive interventions in favor of monitoring indolent diseases to prevent unnecessary medicalization and harm.

12

Publications

380

Citations

47

Authors

29

Institutions

Publications per year

2017–2026

4

Authors

47

  1. KS
    Ketil Størdal

    Norwegian Institute of Public Health, Norway

    1 publications · 41 citations

    1

    h-index

  2. AT
    Andreas Trobisch

    Medical University of Graz, Austria

    1 publications · 41 citations

    1

    h-index

  3. AN
    Amy N. Luckenbaugh

    Vanderbilt University Medical Center, United States

    1 publications · 22 citations

    1

    h-index

  4. WR
    W. Rob Douma

    University of Groningen, Netherlands

    1 publications · 16 citations

    1

    h-index

  5. TA
    Ted A. Skolarus

    University of Michigan, United States

    1 publications · 22 citations

    1

    h-index

1–5 of 47

Venues

  1. PubMed

    Repository · 2 publications · 25 citations

    2

    h-index

  2. Breast Cancer Research

    BCR · 1 publications · 15 citations

    1

    h-index

  3. European Respiratory Journal

    1 publications · 16 citations

    1

    h-index

  4. British Journal of Urology

    1 publications · 97 citations

    1

    h-index

  5. JAMA Oncology

    1 publications · 15 citations

    1

    h-index

1–5